Covered recipient · General Payments record
PAUL A SPECHLER
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2018–2024
$233.80
- Reported across 13 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $203.40 | 11 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Bayer HealthCare Pharmaceuticals Inc. | $39.27 | 2 |
| Novo Nordisk AS | $35.02 | 2 |
| ABBVIE INC. | $30.55 | 2 |
| Corium, Inc. | $29.92 | 1 |
| Acerta Pharma LLC | $26.95 | 2 |
| Biogen, Inc. | $23.44 | 1 |
| GlaxoSmithKline, LLC. | $18.25 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (11)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $14.15 | 10/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106144906 | CMS |
| ABBVIE INC. | $16.40 | 12/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106144908 | CMS |
| AstraZeneca Pharmaceuticals LP | $13.60 | 10/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104398825 | CMS |
| AstraZeneca Pharmaceuticals LP | $13.35 | 12/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104502902 | CMS |
| Bayer Healthcare Pharmaceuticals Inc. | $21.48 | 10/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1086174500 | CMS |
| Bayer Healthcare Pharmaceuticals Inc. | $17.79 | 12/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1086162584 | CMS |
| Biogen, Inc. | $23.44 | 12/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104841343 | CMS |
| Corium, LLC | $29.92 | 11/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100200759 | CMS |
| GlaxoSmithKline, LLC. | $18.25 | 09/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116616616 | CMS |
| Novo Nordisk Inc | $17.58 | 10/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097762738 | CMS |
| Novo Nordisk Inc | $17.44 | 12/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097312272 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2020, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2020 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.